Pre-clinical work across skin, lung, liver, and bone models has reported tissue-repair activity, attributed to fibroblast restoration, antioxidant signaling, anti-inflammatory effects, and matrix-protein synthesis
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
BPC-157 is a different category of approach
Representative images of positive SMAD2 staining (arrows) in the (a) alveolar and (b) small airway wall tissue
Mechanistic pathways of selenium in the treatment of graves disease and graves orbitopathy
Acknowledgements The authors would like to sincerely thank the following individuals and institutions who made vital contributions to this study: We thank Rhyad Al-issa from the Department of Biochemistry, College of Medicine, King Khalid University, for his technical support in the preparation of the electron microscopic slides